The Management of Autoimmune Bullous Skin Disorders in the Era of COVID-19 Pandemic: A Single Center, Retrospective, Cross-sectional Study
-
Published:2023-06-21
Issue:2
Volume:17
Page:41-45
-
ISSN:1307-394X
-
Container-title:Journal of the Turkish Academy of Dermatology
-
language:
-
Short-container-title:jtad
Author:
Üstünbaş Uzunçakmak Tuğba KevserORCID,
Yücesoy Sera NurORCID,
Kutlubay ZekayiORCID
Publisher
Galenos Yayinevi
Subject
General Engineering
Reference30 articles.
1. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - The latest 2019 novel coronavirus outbreak in Wuhan, China;Hui;Int J Infect Dis,2020
2. Risk factors for 2019 novel coronavirus disease (COVID-19) patients progressing to critical illness: a systematic review and meta-analysis;Xu;Aging (Albany NY),2020
3. 3. Gheisari M, Faraji Z, Dadras MS, Nasiri S, Robati RM, Moravvej H, Tehranchinia Z, Ghalamkarpour F, Namazi N, Nobari NN. Methylprednisolone pulse therapy plus adjuvant therapy for pemphigus vulgaris: an analysis of 10 years' experience on 312 patients. Dermatol Ther 2019;32:e13057.
4. Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses;KM;Lancet Infect Dis,2009
5. Concurrent cytomegalovirus and herpes simplex virus infection in pemphigus vulgaris treated with rituximab and prednisolone;Chiu;Acta Derm Venereol,2013